SG148840A1 - Indole derivatives useful for the treatment of cns disorders - Google Patents

Indole derivatives useful for the treatment of cns disorders

Info

Publication number
SG148840A1
SG148840A1 SG200501564-9A SG2005015649A SG148840A1 SG 148840 A1 SG148840 A1 SG 148840A1 SG 2005015649 A SG2005015649 A SG 2005015649A SG 148840 A1 SG148840 A1 SG 148840A1
Authority
SG
Singapore
Prior art keywords
treatment
cns disorders
indole derivatives
derivatives useful
useful
Prior art date
Application number
SG200501564-9A
Other languages
English (en)
Inventor
Benny Bang-Andersen
Jakob Felding
Jan Kehler
Kim Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of SG148840A1 publication Critical patent/SG148840A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG200501564-9A 2000-06-14 2001-06-13 Indole derivatives useful for the treatment of cns disorders SG148840A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000919 2000-06-14
US21244500P 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
SG148840A1 true SG148840A1 (en) 2009-01-29

Family

ID=26068835

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200501564-9A SG148840A1 (en) 2000-06-14 2001-06-13 Indole derivatives useful for the treatment of cns disorders

Country Status (20)

Country Link
US (2) US6890916B2 (ja)
EP (1) EP1294710B1 (ja)
JP (1) JP2004503550A (ja)
KR (1) KR20030007967A (ja)
AR (1) AR028685A1 (ja)
AT (2) ATE297391T1 (ja)
AU (2) AU7388101A (ja)
BG (1) BG107449A (ja)
CA (1) CA2411412C (ja)
CZ (1) CZ200335A3 (ja)
DE (2) DE60130691T2 (ja)
DK (1) DK1468996T3 (ja)
ES (2) ES2290587T3 (ja)
HR (1) HRP20021008A2 (ja)
HU (1) HUP0301735A2 (ja)
NO (1) NO323236B1 (ja)
NZ (1) NZ523076A (ja)
PT (2) PT1468996E (ja)
SG (1) SG148840A1 (ja)
WO (1) WO2001096328A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165274B1 (es) * 1999-06-04 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
EP1468996B1 (en) * 2000-06-14 2007-09-26 H. Lundbeck A/S Indole derivatives for the treatment of CNS disorders
ES2172436B1 (es) 2000-10-31 2004-01-16 Almirall Prodesfarma Sa Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
WO2003102097A1 (en) * 2002-05-31 2003-12-11 H. Lundbeck A/S The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole
WO2004020437A1 (en) * 2002-08-29 2004-03-11 H. Lundbeck A/S S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2004108671A1 (en) * 2003-06-06 2004-12-16 Suven Life Sciences Limited Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
GB0708186D0 (en) * 2007-04-27 2007-06-06 Merck Sharp & Dohme Therapeutic compounds
SE531698C2 (sv) 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028293A1 (en) * 1996-12-20 1998-07-02 H.Lundbeck A/S Indane or dihydroindole derivatives
WO1999011619A1 (en) * 1997-09-04 1999-03-11 Merck Sharp & Dohme Limited Phenylindole derivatives as 5-ht2a receptor ligands
WO1999058525A1 (en) * 1998-05-13 1999-11-18 Eli Lilly And Company Limited Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
WO2000031074A2 (en) * 1998-11-19 2000-06-02 Eli Lilly And Company Limited Indole derivatives and their use as serotonin receptor ligands

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds
WO1999010346A1 (en) * 1997-08-22 1999-03-04 Eli Lilly And Company Limited Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
AU2494300A (en) * 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
EP1200072A2 (en) * 1999-05-12 2002-05-02 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
CN1158258C (zh) * 1999-06-24 2004-07-21 东丽株式会社 肾上腺素能α1B受体拮抗药
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998028293A1 (en) * 1996-12-20 1998-07-02 H.Lundbeck A/S Indane or dihydroindole derivatives
WO1999011619A1 (en) * 1997-09-04 1999-03-11 Merck Sharp & Dohme Limited Phenylindole derivatives as 5-ht2a receptor ligands
WO1999058525A1 (en) * 1998-05-13 1999-11-18 Eli Lilly And Company Limited Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
WO2000031074A2 (en) * 1998-11-19 2000-06-02 Eli Lilly And Company Limited Indole derivatives and their use as serotonin receptor ligands

Also Published As

Publication number Publication date
JP2004503550A (ja) 2004-02-05
US6890916B2 (en) 2005-05-10
HUP0301735A2 (hu) 2003-08-28
DE60111379T2 (de) 2006-03-16
PT1468996E (pt) 2007-11-28
CA2411412C (en) 2008-09-02
EP1294710A1 (en) 2003-03-26
US20030191133A1 (en) 2003-10-09
BG107449A (bg) 2003-09-30
CZ200335A3 (cs) 2003-04-16
ATE374197T1 (de) 2007-10-15
US20050176729A1 (en) 2005-08-11
PT1294710E (pt) 2005-10-31
DK1468996T3 (da) 2008-01-07
ATE297391T1 (de) 2005-06-15
AR028685A1 (es) 2003-05-21
AU2001273881B8 (en) 2006-02-09
NO20026005D0 (no) 2002-12-13
EP1294710B1 (en) 2005-06-08
KR20030007967A (ko) 2003-01-23
AU2001273881B2 (en) 2005-12-22
DE60130691T2 (de) 2008-07-17
WO2001096328A1 (en) 2001-12-20
US7276508B2 (en) 2007-10-02
DE60130691D1 (de) 2007-11-08
DE60111379D1 (de) 2005-07-14
NO20026005L (no) 2002-12-13
ES2290587T3 (es) 2008-02-16
CA2411412A1 (en) 2001-12-20
NZ523076A (en) 2004-09-24
HRP20021008A2 (en) 2005-02-28
NO323236B1 (no) 2007-02-05
AU7388101A (en) 2001-12-24
ES2243508T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
AU8187701A (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
AU2001271706A1 (en) Use of substituted indole compounds for treating breast disorders
IL160043A0 (en) Process for the preparation of indole derivatives
SG148840A1 (en) Indole derivatives useful for the treatment of cns disorders
HRP20030052A2 (en) 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders
IL153605A0 (en) Indole derivatives useful for the treatment of cns disorders
HK1039333A1 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
IL153254A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1468686T1 (sl) S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj
NO20026028D0 (no) Indolderivater nyttige for behandlingen av CNS-forstyrrelser
AU2002221566A1 (en) Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153234A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
AU6007900A (en) Azetidine carboxamide derivatives for the treatment of cns disorders
AP2000001963A0 (en) Paroxetine ascorbate.
SI1451177T1 (sl) Substituirani 2-pirolidin-2-il-1H-indolni derivati za zdravljenje migrene
AP2000001958A0 (en) Paroxetine 10-camphorsulfornate for treatment of CNS disorders.
SI1147083T1 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression